Professor, Surgery, Oregon Health and Science University School of Medicine
General Surgery
Dr. Rodney F. Pommier, MD
|
|
Give Review
Rodney F. Pommier, MD works in the field of General Surgery. He attended Oregon Health & Science University School of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Rodney F. Pommier, MD is also published. He has 80 publications published. The lastest publication: "Submandibular gland carcinoma ex pleomorphic adenoma. Report of a case with cytologic features and diagnostic pitfalls.' Rodney Pommier accepts Medicare.
Publications
- Surgical Treatment of Small Bowel Neuroendocrine Tumors.
- Expanded criteria for carcinoid Liver debulking: Maintaining survival and increasing the number of eligible patients.
- Impact of Prior Chemotherapy Use on the Efficacy of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT...
- The international normalized ratio overestimates coagulopathy in patients after major hepatectomy.
- Phase I Trial of Preoperative Chemoradiation plus Sorafenib for High-Risk Extremity Soft Tissue Sarcomas with Dynamic Contrast-Enhanced MRI Correlates.
- Correlation of Breast Cancer Axillary Lymph Node Metastases With Stem Cell Mutations.
- Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients.
- Coagulopathy after a Liver resection: is it over diagnosed and over treated?
- Laparoscopic surgical exploration is an effective strategy for locating occult primary Neuroendocrine tumors.
- Fresh surgical specimens yield Breast stem/progenitor cells and reveal their oncogenic abnormalities.
- Post-Transplant Lymphoproliferative Disorder at the Site of Recurrent Breast Abscesses.
- Using complications associated with postmastectomy radiation and immediate Breast reconstruction to improve surgical decision making.
- Factors influencing accuracy of axillary sentinel lymph node frozen section for breast Cancer.
- Characterizing the HER2/neu status and metastatic potential of breast Cancer stem/progenitor cells.
- Incidence and outcomes of contralateral breast Cancers.
- Fine-needle aspiration cytology of medullary Breast carcinoma: report of two cases and review of the literature with emphasis on differential diagnosis.
- Operative resection of primary carcinoid neoplasms in patients with Liver metastases yields significantly better survival.
- The relationships among clinician delay of diagnosis of breast Cancer and tumor size, nodal status, and stage.
- Breast fine-needle aspirates with scant cellularity are clinically useful.
- Relationships among delay of diagnosis, extent of disease, and survival in patients with Abdominal carcinoid tumors.
- Estrogen and androgen receptors as comediators of breast Cancer cell proliferation: providing a new therapeutic tool.
- Comparing the cost-effectiveness of the triple test score to traditional methods for evaluating palpable Breast masses.
- Dehydroepiandrosterone sulfate causes proliferation of estrogen receptor-positive breast Cancer cells despite treatment with fulvestrant.
- A new score for the evaluation of palpable Breast masses in women under age 40.
- The impact of hormone replacement therapy on the detection and stage of breast Cancer.
- Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast Cancer and benign stem/progenitor cell populations.
- Serum peptide profiles in patients with carcinoid Tumors.
- The effect of high dehydroepiandrosterone sulfate levels on tamoxifen blockade and breast Cancer progression.
- Understanding the biologic mechanisms responsible for breast-Cancer progression during tamoxifen or fulvestrant treatment.
- DNA fingerprints provide a patient-specific breast Cancer marker.
- Breast Cancer severity score is an innovative system for prognosis.
- Transgenic introduction of androgen receptor into estrogen-receptor-, progesterone-receptor-, and androgen-receptor-negative breast Cancer cells renders them responsiv...
- Delayed removal of 3M vein coupler does not disturb the anastomosis.
- Hepatic artery chemoinfusion with chemoembolization for neuroendocrine Cancer with progressive hepatic metastases despite octreotide therapy.
- Improved breast Cancer survival among hormone replacement therapy users is durable after 5 years of additional follow-up.
- The NANETS consensus guidelines for the diagnosis and management of gastroIntestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rec...
- NANETS treatment guidelines: well-differentiated Neuroendocrine tumors of the stomach and pancreas.
- A new hormonal therapy for estrogen receptor-negative breast Cancer.
- Evolving diagnostic and treatment strategies for pancreatic Neuroendocrine tumors.
- High dehydroepiandrosterone-sulfate predicts breast Cancer progression during new aromatase inhibitor therapy and stimulates breast Cancer cell growth in tissue cultur...
- Usefulness of the triple test score for palpable Breast masses; discussion 1012-3.
- Usefulness of preoperative lymphoscintigraphy for the identification of sentinel lymph nodes in melanoma.
- Distribution and functional significance of somatostatin receptors in Malignant melanoma.
- Lymph nodes in the human female Breast: a review of their detection and significance.
- Office-based wire-guided open Breast biopsy under local anesthesia is accurate and cost effective.
- Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in Malignant carcinoid syndrome.
- Submandibular Gland carcinoma ex pleomorphic adenoma. Report of a case with cytologic features and diagnostic pitfalls.
- The current status of somatostatin receptors in Malignant melanoma.
- Results of treatment of inferior vena cava syndrome with expandable metallic stents.
- Accurate evaluation of palpable Breast masses by the triple test score.
- Relationships between operative approaches and outcomes in esophageal Cancer.
- Surgical treatment of metastatic melanoma.
- Accurate and cost-effective evaluation of Breast masses in males.
- Specimen adequacy in Breast fine-needle aspiration biopsy.
- Changes in serum estrogen levels in women during tamoxifen therapy.
- Improved outcome of surgical flaps treated with topical dimethylsulfoxide.
- Diagnosis of palpable Breast lesions in younger women by the modified triple test is accurate and cost-effective.
- Synchronous non-small cell lung Cancers.
- Synchronous colon primaries have the same prognosis as solitary colon Cancers.
- Erythromycin stimulates gastric emptying after esophagectomy with gastric replacement: a randomized clinical trial.
- Comparison of Adrenal and extraAdrenal pheochromocytomas.
- An improved method of needle localized biopsy of nonpalpable lesions of the Breast.
- Results of cisplatin hyperthermic isolation perfusion for stage IIIA and IIIAB extremity melanoma.
- Pharmacokinetics and results of dose escalation in cis-platin hyperthermic isolation limb perfusion.
- Changes in serum sex steroid levels during megestrol acetate therapy.
- Treatment of metastatic carcinoid Tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization.
- Use of the "triple test" for palpable Breast lesions yields high diagnostic accuracy and cost savings.
- Tamoxifen in the treatment and chemoprevention of breast Cancer.
- Breast Cancer in pregnancy--a diagnostic and therapeutic challenge.
- Nonanatomic hepatic resection for secondary hepatic Tumors with special reference to hemostatic technique.
- Cytotoxicity of dimethyl sulfoxide and antineoplastic combinations against human Tumors.
- Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremities.
- Synergistic cytotoxicity between dimethyl sulfoxide and antineoplastic agents against ovarian Cancer in vitro.
- Hepatic resection for primary and secondary neoplasms of the Liver.
- The mechanism of hormone-sensitive breast Cancer progression on antiestrogen therapy. Implications for treatment and protocol planning.
- Follow-up of patients after primary colorectal Cancer resection.
- Management of Adrenal neoplasms.
- An eleven-year experience with adrenocortical Carcinoma.
- Synergistic cytotoxicity of combinations of dimethyl sulfoxide and antineoplastic agents against P388 leukemia in CD-F1 mice.
Schools
Oregon Health And Science University School Of Medicine
Oregon Health and Science University
Fell Oreg Health Scis University
Meml Sloan Kettering
Procedures Preformed
- Adrenalectomy
- Appendectomy, Open
- Biliary Drainage
- Biopsy of Breast
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Oregon Health & Science University -
Oregon Health & Science University School of Medicine
Drug Facts
| NPI NUMBER | 1114932613 | |
| NPPES Provider LastName | POMMIER | |
| NPPES Provider FirstName | RODNEY | |
| NPPES Provider ZIPCode | 972393011 | |
| NPPES Provider State | OR | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 222.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 4.95 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114932613 |
| Last Name Of The Provider | POMMIER |
| First Name Of The Provider | RODNEY |
| View All |
Similar Doctors
|
|
Dr. Arpana M. Naik, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Rehan S. Ahmad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce M. Wolfe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven G. Leeds, MD |
|
|
Dr. Allison C. Nauta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexis M. Moren, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott G. Louis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gordon M. Riha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristen P. Massimino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Zatarain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily F. Cleveland, ND
This Doctor is OpenDoctor Recommended.
|